These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B. Buddenkotte J; Stroh C; Engels IH; Moormann C; Shpacovitch VM; Seeliger S; Vergnolle N; Vestweber D; Luger TA; Schulze-Osthoff K; Steinhoff M J Invest Dermatol; 2005 Jan; 124(1):38-45. PubMed ID: 15654951 [TBL] [Abstract][Full Text] [Related]
28. Proteinase-Activated Receptor-2 Sensitivity of Amplified TRPA1 Activity in Skeletal Muscle Afferent Nerves and Exercise Pressor Reflex in Rats with Femoral Artery Occlusion. Xing J; Li J Cell Physiol Biochem; 2017; 44(1):163-171. PubMed ID: 29131007 [TBL] [Abstract][Full Text] [Related]
29. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo. Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374 [TBL] [Abstract][Full Text] [Related]
30. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Roy SS; Saifeddine M; Loutzenhiser R; Triggle CR; Hollenberg MD Br J Pharmacol; 1998 Apr; 123(7):1434-40. PubMed ID: 9579740 [TBL] [Abstract][Full Text] [Related]
31. Toward drugs for protease-activated receptor 2 (PAR2). Yau MK; Liu L; Fairlie DP J Med Chem; 2013 Oct; 56(19):7477-97. PubMed ID: 23895492 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. Kawabata A; Saifeddine M; Al-Ani B; Leblond L; Hollenberg MD J Pharmacol Exp Ther; 1999 Jan; 288(1):358-70. PubMed ID: 9862790 [TBL] [Abstract][Full Text] [Related]
33. Progression of Time-Dependent Changes to the Mechanisms of Vasodilation by Protease-Activated Receptor 2 in Metabolic Syndrome. Maruyama K; McGuire JJ; Kagota S Biol Pharm Bull; 2017; 40(12):2039-2044. PubMed ID: 29199228 [TBL] [Abstract][Full Text] [Related]